Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
Overview
The Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership was a collaboration between Bristol-Myers Squibb and Sanofi, primarily focused on the development and commercialization of pharmaceuticals in various therapeutic areas. The partnership was well-known for its cardiovascular drugs, notably in improving patients' lives through innovative treatment solutions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.